Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NORDNordicus Partners Corp

Nasdaq · CIK 0001011060
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC8742 Services-Management Consulting Services
FY end0331
XBRL facts393

Identity from submissions API

NameNordicus Partners Corp
CIK0001011060
TickersNORD
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC8742 Services-Management Consulting Services
EIN043186647
LEI—
Fiscal year end0331
State of incorporationDE DE
Phone508-523-3141
Website—
Investor website—
Owner org07 Trade & Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • EKIMAS Corp (2020-04-06T04:00:00.000Z → 2023-05-03T04:00:00.000Z)
  • AdvanSource Biomaterials Corp (2008-10-30T04:00:00.000Z → 2020-04-03T04:00:00.000Z)
  • CARDIOTECH INTERNATIONAL INC (1996-07-01T04:00:00.000Z → 2008-09-08T04:00:00.000Z)
Business address
280 SOUTH BEVERLY DR.
SUITE 505
BEVERLY HILLS
CA
90212
CA
Mailing address
280 SOUTH BEVERLY DR.
SUITE 505
BEVERLY HILLS
CA
90212
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

622 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 PRE 14C PRE 14C 0001493152-26-052591 001-11737 261562917 34 630656
2026-11-13 NT 10-Q NT 10-Q 0001493152-26-051705 001-11737 261552332 34 40175
2026-11-12 4 4 0001493152-26-051124 5725
2026-11-10 4 4 0001493152-26-051067 5619
2026-11-10 4 4 0001493152-26-051065 5622
2026-11-10 8-K 8-K 1.01,2.03,3.02,5.02,9.01 0001493152-26-050992 001-11737 261540946 34 14483676 1 1
2026-11-04 8-K 8-K 3.02,9.01 0001493152-26-049955 001-11737 261522093 34 209529 1 1
2026-10-29 CERT 0001011060_8A_Cert_NORD.pdf 0001354457-26-001038 001-11737 261502274 34 181237
2026-10-29 8-A12B 8-A12B 0001493152-26-049267 001-11737 261501680 34 20930
2026-10-21 8-K 8-K 1.01,2.03,9.01 0001493152-26-047909 001-11737 261476056 34 236379 1 1
2026-10-14 8-K 8-K 1.01,2.03,9.01 0001493152-26-046939 001-11737 261458411 34 238308 1 1
2026-09-28 10-Q 10-Q 0001493152-26-044551 001-11737 261416938 34 5320535 1 1
2026-09-17 8-K 8-K 1.01,2.03,3.02,9.01 0001493152-26-042971 001-11737 261384732 34 8295789 1 1
2026-09-04 8-K 8-K 5.02,9.01 0001493152-26-041470 001-11737 261360316 34 25640277 1 1
2026-08-13 NT 10-Q NT 10-Q 0001493152-26-037826 001-11737 261274159 34 39626
2026-07-14 10-K 10-K 0001493152-26-033203 001-11737 261175063 34 7276271 1 1
2026-07-13 8-K 8-K 5.02,9.01 0001493152-26-032965 001-11737 261170141 34 200710 1 1
2026-06-29 NT 10-K NT 10-K 0001493152-26-030445 001-11737 261132037 34 36971
2026-06-23 8-K 8-K 1.01,3.02,9.01 0001493152-26-029772 001-11737 261110861 34 204689 1 1
2026-02-13 10-Q 10-Q 0001493152-26-006646 001-11737 26631522 34 5488952 1 1
2026-02-04 8-K 8-K 8.01,9.01 0001493152-26-005074 001-11737 26597247 34 8335639 1 1
2026-01-05 8-K 8-K 1.01,3.02,9.01 0001493152-26-000353 001-11737 26505540 34 204452 1 1
2025-12-05 8-K 8-K 1.01,3.02,9.01 0001493152-25-026281 001-11737 251551340 34 202958 1 1
2025-11-14 10-Q 10-Q 0001493152-25-023246 001-11737 251483858 34 4920312 1 1
2025-10-28 4 4 0001493152-25-019880 9786
2025-10-14 4 4 0001493152-25-017946 27590
2025-10-14 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-017947 005-48655 251389964 34 12609
2025-10-14 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-017944 005-48655 251389965 34 12922
2025-09-29 4 xslF345X05/ownership.xml 0001493152-25-016130 19817
2025-09-29 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-016129 005-48655 251357975 34 12367
2025-09-19 8-K 8-K 1.01,3.02,9.01 0001493152-25-014113 001-11737 251324679 34 203674 1 1
2025-08-20 10-Q 10-Q 0001641172-25-024884 001-11737 251233220 34 4365527 1 1
2025-08-14 NT 10-Q NT 10-Q 0001641172-25-023658 001-11737 251214010 34 38334
2025-08-11 8-K 8-K 7.01,9.01 0001641172-25-022954 001-11737 251201547 34 26037699 1 1
2025-08-07 8-K 8-K 5.02,9.01 0001641172-25-022537 001-11737 251192120 34 373614 1 1
2025-08-05 424B3 424B3 0001641172-25-022199 333-283709 251184359 33 1207024 1 1
2025-07-29 10-K 10-K 0001641172-25-021335 001-11737 251161114 34 6617591 1 1
2025-07-03 8-K 8-K 1.01,3.02,9.01 0001641172-25-017697 001-11737 251103786 34 204577 1 1
2025-07-01 8-K 8-K 5.02,9.01 0001641172-25-017351 001-11737 251096135 34 340331 1 1
2025-06-27 NT 10-K NT 10-K 0001641172-25-016816 001-11737 251082555 34 36440
2025-06-11 8-K 8-K 1.01,3.02,9.01 0001641172-25-014640 001-11737 251038870 34 249115 1 1
2025-06-04 424B3 424B3 0001641172-25-013513 333-283709 251021770 33 605884
2025-04-02 10-Q form10-q.htm 0001641172-25-002308 001-11737 25802677 34 5425862 1 1
2025-04-01 8-K form8-k.htm 7.01,9.01 0001641172-25-002086 001-11737 25800118 34 2176029 1 1
2025-03-06 8-K form8-k.htm 7.01,9.01 0001493152-25-009356 001-11737 25714681 34 9925193 1 1
2025-02-14 NT 10-Q formnt10-q.htm 0001493152-25-006511 001-11737 25622237 34 39779
2025-01-02 8-K form8-k.htm 7.01,9.01 0001493152-25-000059 001-11737 25502084 34 4020099 1 1
2025-01-02 8-K form8-k.htm 1.01,3.02,9.01 0001493152-25-000003 001-11737 25500059 34 346017 1 1
2024-12-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-24-003956 333-283709 241591023 33 2087
2024-12-26 CORRESP filename1.htm 0001493152-24-052056 12778
2024-12-26 UPLOAD filename1.pdf 0000000000-24-014258 333-283709 40370
2024-12-23 S-1/A forms-1a.htm 0001493152-24-051214 333-283709 241570211 33 6673360 1 1
2024-12-17 S-8 forms-8.htm 0001493152-24-050370 333-283862 241554725 33 189011
2024-12-11 4 xslF345X05/ownership.xml 0001493152-24-049598 5499
2024-12-10 S-1 forms-1.htm 0001493152-24-049456 333-283709 241538163 33 89667927 1 1
2024-12-10 3 xslF345X02/ownership.xml 0001493152-24-049454 4278
2024-12-10 3 xslF345X02/ownership.xml 0001493152-24-049453 4308
2024-12-10 3 xslF345X02/ownership.xml 0001493152-24-049430 4232
2024-12-10 4 xslF345X05/ownership.xml 0001493152-24-049433 19059
2024-12-10 4 xslF345X05/ownership.xml 0001493152-24-049432 5295
2024-12-10 4 xslF345X05/ownership.xml 0001493152-24-049431 5293
2024-12-10 SC 13D/A formsc13da.htm 0001493152-24-049437 005-48655 241537977 34 53528
2024-12-10 SC 13D/A formsc13da.htm 0001493152-24-049436 005-48655 241537975 34 52396
2024-12-10 SC 13D formsc13d.htm 0001493152-24-049435 005-48655 241537978 34 51837
2024-12-10 SC 13D formsc13d.htm 0001493152-24-049434 005-48655 241537976 34 51570
2024-12-03 8-K form8-k.htm 1.01,3.02,9.01 0001493152-24-048394 001-11737 241520918 34 22067397 1 1
2024-11-27 4 xslF345X05/ownership.xml 0001493152-24-047967 7990
2024-11-27 4 xslF345X05/ownership.xml 0001493152-24-047965 7989
2024-11-14 10-Q form10-q.htm 0001493152-24-045927 001-11737 241463030 34 3772336 1 1
2024-11-13 SC 13D/A form13da.htm 0001493152-24-045004 005-48655 241452005 34 52895
2024-11-13 SC 13D/A formsc13da.htm 0001493152-24-045002 005-48655 241451991 34 52689
2024-11-13 8-K form8-k.htm 1.01,2.01,3.02,9.01 0001493152-24-044999 001-11737 241451974 34 345283 1 1
2024-11-13 8-K form8-k.htm 1.01,2.01,3.02,9.01 0001493152-24-044996 001-11737 241451963 34 347348 1 1
2024-11-07 UPLOAD filename1.pdf 0000000000-24-012394 005-48655 43768
2024-11-07 UPLOAD filename1.pdf 0000000000-24-012393 005-48655 43797
2024-11-05 SC 13D/A formsc13da.htm 0001493152-24-043651 005-48655 241427157 34 53340
2024-11-05 SC 13D/A formsc13da.htm 0001493152-24-043649 005-48655 241427145 34 53387
2024-10-08 DEFR14C formdefr14c.htm 0001493152-24-040382 001-11737 241359103 34 262821
2024-10-07 DEF 14C formdef14c.htm 0001493152-24-039624 001-11737 241356047 34 262742
2024-09-23 UPLOAD filename1.pdf 0000000000-24-010790 005-48655 44685
2024-09-23 UPLOAD filename1.pdf 0000000000-24-010789 005-48655 44625
2024-08-23 SC 13D/A formsc13da.htm 0001493152-24-033661 005-48655 241235495 34 57704
2024-08-23 4 xslF345X05/ownership.xml 0001493152-24-033660 9510
2024-08-19 10-Q form10-q.htm 0001493152-24-033179 001-11737 241221935 34 2949231 1 1
2024-08-13 NT 10-Q formnt10-q.htm 0001493152-24-031685 001-11737 241202865 34 39664
2024-07-03 10-K form10-k.htm 0001493152-24-026126 001-11737 241098173 34 3640291 1 1
2024-07-02 NT 10-K formnt10-k.htm 0001493152-24-025872 001-11737 241092099 34 38220
2024-06-05 3 xslF345X02/ownership.xml 0001493152-24-022780 4101
2024-06-05 SC 13D formsc13d.htm 0001493152-24-022778 005-48655 241022638 34 48915
2024-06-05 SC 13D formsc13d.htm 0001493152-24-022675 005-48655 241021506 34 50745
2024-06-04 4 xslF345X05/ownership.xml 0001493152-24-022567 8063
2024-06-04 SC 13D/A formsc13da.htm 0001493152-24-022565 005-48655 241019011 34 56159
2024-06-04 8-K form8-k.htm 5.02,9.01 0001493152-24-022512 001-11737 241017135 34 231706 1 1
2024-05-28 PRE 14C formpre14c.htm 0001493152-24-021625 001-11737 24992748 34 245808
2024-05-16 8-K form8-k.htm 1.01,2.01,3.02,9.01 0001493152-24-020152 001-11737 24953889 34 5377210 1 1
2024-03-26 SC 13D/A formsc13da.htm 0001493152-24-011300 005-48655 24783661 34 54135
2024-03-26 4 xslF345X05/ownership.xml 0001493152-24-011299 22786
2024-03-26 SC 13D/A formsc13da.htm 0001493152-24-011287 005-48655 24783240 34 55207
2024-03-26 4 xslF345X05/ownership.xml 0001493152-24-011286 4770
2024-02-06 10-Q form10-q.htm 0001493152-24-005068 001-11737 24599515 34 2607756 1 1
2023-12-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-12-14 17:00:00 9999999995-23-003619 333-274588 231488680 33 1983
2023-12-11 CORRESP filename1.htm 0001493152-23-044350 13030
2023-12-06 S-1/A forms-1a.htm 0001493152-23-043857 333-274588 231469495 33 27286650 1 1
2023-11-27 S-1/A forms-1a.htm 0001493152-23-042793 333-274588 231441080 33 26743916 1 1
2023-11-27 CORRESP filename1.htm 0001493152-23-042794 21347
2023-11-27 UPLOAD filename1.pdf 0000000000-23-012855 44653
2023-11-13 10-Q form10-q.htm 0001493152-23-040448 001-11737 231398065 34 2748135 1 1
2023-11-13 CORRESP filename1.htm 0001493152-23-040251 25788
2023-11-13 S-1/A forms-1a.htm 0001493152-23-040245 333-274588 231394785 33 26752088 1 1
2023-11-07 UPLOAD filename1.pdf 0000000000-23-012159 46699
2023-10-24 S-1/A forms-1a.htm 0001493152-23-038168 333-274588 231343481 33 26701380 1 1
2023-10-24 CORRESP filename1.htm 0001493152-23-038169 35889
2023-10-16 UPLOAD filename1.pdf 0000000000-23-011255 53615
2023-09-19 S-1 forms-1.htm 0001493152-23-033099 333-274588 231264655 33 4804950 1 1
2023-09-18 SC 13D/A formsc13da.htm 0001493152-23-032908 005-48655 231261010 34 52992
2023-09-13 4 xslF345X05/ownership.xml 0001493152-23-032457 18948
2023-08-31 SC 13D/A formsc13da.htm 0001493152-23-030747 005-48655 231227572 34 53508
2023-08-31 4 xslF345X05/ownership.xml 0001493152-23-030739 4686
2023-08-18 10-Q form10-q.htm 0001493152-23-029390 001-11737 231184421 34 2403557 1 1
2023-08-14 NT 10-Q formnt10-q.htm 0001493152-23-027965 001-11737 231166060 34 36772
2023-08-08 4 xslF345X05/ownership.xml 0001493152-23-027117 37518
2023-07-20 10-K/A form10-ka.htm 0001493152-23-024963 001-11737 231097698 34 8793267 1 1
2023-07-14 10-K form10-k.htm 0001493152-23-024627 001-11737 231089897 34 8810661 1 1
2023-06-29 NT 10-K formnt10-k.htm 0001493152-23-022892 001-11737 231056858 34 37630
2023-06-23 4 xslF345X04/ownership.xml 0001493152-23-022171 4722
2023-06-20 8-K form8-k.htm 1.01,2.01,3.02,9.01 0001493152-23-021799 001-11737 231024070 34 317234 1 1
2023-06-13 8-K form8-k.htm 5.02,9.01 0001493152-23-021026 001-11737 231010863 34 216665 1 1
2023-05-23 8-K form8-k.htm 4.01,9.01 0001493152-23-018649 001-11737 23946464 34 546271 1 1
2023-05-22 8-K form8-k.htm 5.03,7.01,9.01 0001493152-23-018489 001-11737 23943563 34 796374 1 1
2023-05-03 8-K form8-k.htm 5.02,9.01 0001493152-23-015277 001-11737 23882656 34 341080 1 1
2023-03-01 8-K form8-k.htm 1.01,2.01,3.02,5.01,5.02,5.06,8.01,9.01 0001493152-23-006431 001-11737 23694828 34 5832396 1 1
2023-02-14 10-Q form10-q.htm 0001493152-23-004887 001-11737 23629302 34 2366694 1 1
2022-11-30 8-K form8-k.htm 3.02,9.01 0001493152-22-033965 001-11737 221434207 34 400426 1 1
2022-11-14 10-Q form10-q.htm 0001493152-22-031822 001-11737 221383372 34 2249961 1 1
2022-10-17 8-K form8-k.htm 1.01,9.01 0001493152-22-028536 001-11737 221313548 34 241827 1 1
2022-10-11 8-K form8-k.htm 4.01,9.01 0001493152-22-028097 001-11737 221303655 34 215001 1 1
2022-09-08 3 xslF345X02/ownership.xml 0001493152-22-025361 3639
2022-09-08 SC 13D formsc13d.htm 0001493152-22-025358 005-48655 221233464 34 50039
2022-08-26 10-Q form10-q.htm 0001493152-22-024151 001-11737 221204700 34 2059642 1 1
2022-08-15 NT 10-Q formnt10-q.htm 0001493152-22-022639 001-11737 221163330 34 37832
2022-07-21 3 xslF345X02/ownership.xml 0001493152-22-019970 3784
2022-07-21 SC 13D formsc13d.htm 0001493152-22-019968 005-48655 221096013 34 48712
2022-07-08 10-K/A form10-ka.htm 0001493152-22-018874 001-11737 221073800 34 373553 1 1
2022-06-28 10-K form10-k.htm 0001493152-22-017952 001-11737 221049640 34 2788687 1 1
2022-06-28 SC 13D/A formsc13da.htm 0001493152-22-017895 005-48655 221046264 34 50758
2022-06-27 4 xslF345X03/ownership.xml 0001493152-22-017891 6249
2022-04-12 8-K form8-k.htm 1.01,3.02,9.01 0001493152-22-009732 001-11737 22823071 34 310031 1 1
2022-03-21 8-K form8-k.htm 1.01,3.02,5.01,9.01 0001493152-22-007337 001-11737 22754563 34 214122 1 1
2022-03-21 SC 13D formsc13d.htm 0001493152-22-007335 005-48655 22754562 34 48933
2022-03-21 4 xslF345X03/ownership.xml 0001493152-22-007333 4657
2022-01-14 10-Q form10-q.htm 0001493152-22-001233 001-11737 22531470 34 2028064 1 1
2021-12-29 DEF 14C formdef14c.htm 0001493152-21-032654 001-11737 211527476 34 108804
2021-11-12 10-Q form10-q.htm 0001493152-21-028097 001-11737 211402013 34 1841878 1 1
2021-11-01 PRE 14C formpre14c.htm 0001493152-21-026882 001-11737 211367740 34 108837
2021-10-18 3 xslF345X02/ownership.xml 0001493152-21-025675 3807
2021-10-18 SC 13D formsc13d.htm 0001493152-21-025673 005-48655 211327943 34 53123
2021-10-18 8-K form8-k.htm 1.01,3.02,5.01,5.02,9.01 0001493152-21-025667 001-11737 211327831 34 804797 1 1
2021-09-23 10-Q form10-q.htm 0001493152-21-023473 001-11737 211272137 34 1623214 1 1
2021-09-22 10-K/A form10-ka.htm 0001493152-21-023352 001-11737 211269214 34 138482
2021-09-22 10-K form10-k.htm 0001493152-21-023342 001-11737 211269061 34 3097950 1
2021-09-13 10-Q form10-q.htm 0001493152-21-022555 001-11737 211250206 34 1793246 1
2021-09-10 10-Q form10-q.htm 0001493152-21-022389 001-11737 211246757 34 1716811 1
2021-09-10 10-Q form10-q.htm 0001493152-21-022332 001-11737 211245362 34 1618021 1
2021-08-27 8-K form8-k.htm 4.01,9.01 0001493152-21-021408 001-11737 211216820 34 43234
2021-07-20 10-K/A form10-ka.htm 0001493152-21-017312 001-11737 211100848 34 165709
2021-07-16 10-K form10-k.htm 0001493152-21-017036 001-11737 211095268 34 3541171 1
2021-06-29 NT 10-K formnt10-k.htm 0001493152-21-015506 001-11737 211056708 34 36440
2020-10-13 8-K form8-k.htm 5.02 0001493152-20-019344 001-11737 201236428 34 26107
2020-06-29 8-K form8-k.htm 8.01 0001493152-20-012198 001-11737 201000237 34 34408
2020-04-06 8-K 200406 ASNB FORM 8K 8.01,9.01 0001011060-20-000012 001-11737 20776721 34 27265
2020-04-03 8-K EKIMAS FORM 8K (200403) 5.03,9.01 0001011060-20-000010 001-11737 20773117 34 26919
2020-04-01 10-Q form10-q.htm 0001493152-20-005627 001-11737 20766107 34 2645930 1
2020-02-18 NT 10-Q FORM 12B-25 FOR DECEMBER 31, 2019 0001556244-20-000002 001-11737 20623776 34 18666
2020-02-06 8-K CURRENT REPORT 2.01,5.02,8.01,9.01 0001213900-20-002787 001-11737 20582794 34 50459
2020-01-24 8-K CURRENT REPORT 5.07 0001213900-20-001736 001-11737 20545327 34 24265
2019-12-30 DEFM14A DEFM14A 0001213900-19-027161 001-11737 191316173 34 4934734
2019-12-17 SC 13D SCHEDULE 13D 0001213900-19-026368 005-48655 191291370 34 941218
2019-12-17 PREM14A PRELIMINARY PROXY STATEMENT 0001213900-19-026373 001-11737 191290651 34 1758371
2019-12-06 4 PRIMARY DOCUMENT 0001556244-19-000112 8591
2019-12-06 4 PRIMARY DOCUMENT 0001556244-19-000111 4740
2019-12-06 4 PRIMARY DOCUMENT 0001556244-19-000110 4686
2019-12-06 4 PRIMARY DOCUMENT 0001556244-19-000109 6484
2019-12-06 4 PRIMARY DOCUMENT 0001556244-19-000108 4934
2019-12-06 4 PRIMARY DOCUMENT 0001556244-19-000107 4907
2019-12-06 4 PRIMARY DOCUMENT 0001556244-19-000106 8412
2019-12-02 8-K CURRENT REPORT 1.01,9.01 0001213900-19-025155 001-11737 191264068 34 944834
2019-12-02 DEFA14A CURRENT REPORT 0001213900-19-025156 001-11737 191264057 34 944724
2019-11-26 8-K CURRENT REPORT 8.01,9.01 0001213900-19-024646 001-11737 191247374 34 48765
2019-11-26 DEFA14A CURRENT REPORT 0001213900-19-024647 001-11737 191247373 34 48685
2019-11-13 10-Q ADVANSOURCE BIOMATERIALS CORPORATION - FORM 10-Q SEC FILING 0001556244-19-000102 001-11737 191214102 34 1719415 1 1
2019-09-30 10-Q ADVANSOURCE BIOMATERIALS CORPORATION - FORM 10-Q SEC FILING 0001556244-19-000097 001-11737 191125707 34 1673238 1 1
2019-08-23 10-K/A ADVANSOURCE BIOMATERIALS CORPORATION - FORM 10-K SEC FILING 0001376474-19-000225 001-11737 191048577 34 2294233 1 1
2019-08-22 10-K 190331 ASNB FORM 10-K 0001556244-19-000078 001-11737 191046597 34 704035
2019-08-14 NT 10-Q 190814 ASNB FORM 12B-25 FOR 190630 FORM 10-Q 0001556244-19-000063 001-11737 191026698 34 17727
2019-07-01 NT 10-K 190701 ASNB FORM 12B-25 FOR 190331 FORM 10-K 0001556244-19-000061 001-11737 19932966 34 17579
2019-02-19 10-Q 181231 ASNB FORM 10-Q 0001556244-19-000027 001-11737 19614424 34 1290430 1
2019-02-14 NT 10-Q FORM 12B-25 FOR MARCH 31, 2009 FORM 10-Q (M0077514.DOC;2) 0001556244-19-000013 001-11737 19607264 34 18400
2018-11-14 10-Q 180930 ASNB FORM 10-Q 0001556244-18-000162 001-11737 181184774 34 1289617 1
2018-08-20 4 PRIMARY DOCUMENT 0001556244-18-000119 5109
2018-08-14 10-Q 180630 ASNB FORM 10-Q 0001556244-18-000107 001-11737 181016276 34 1236626 1
2018-07-30 10-K/A 180331 ASNB FORM 10-KA #1 0001556244-18-000100 001-11737 18976724 34 193471
2018-07-16 10-K 180331 ASNB FORM 10-K 0001556244-18-000089 001-11737 18954341 34 2076247 1
2018-06-29 NT 10-K 180629 ASNB FORM 12B-25 FOR 180331 FORM 10-K 0001556244-18-000083 001-11737 18927990 34 17677
2018-02-14 10-Q ASNB 171231 FORM 10-Q 0001556244-18-000030 001-11737 18610206 34 1312319 1
2017-11-14 10-Q 170930 ASNB FORM 10-Q 0001011060-17-000033 001-11737 171198023 34 1303964 1
2017-09-01 4 PRIMARY DOCUMENT 0001011060-17-000029 4629
2017-08-25 4 PRIMARY DOCUMENT 0001011060-17-000028 4653
2017-08-23 4 PRIMARY DOCUMENT 0001011060-17-000027 4654
2017-08-22 8-K 170822 ASNB FORM 8-K 5.02,9.01 0001011060-17-000026 001-11737 171044286 34 57689
2017-08-21 4 PRIMARY DOCUMENT 0001556244-17-000028 5508
2017-08-21 4 PRIMARY DOCUMENT 0001556244-17-000027 5320
2017-08-21 4 PRIMARY DOCUMENT 0001556244-17-000026 5484
2017-08-21 4 PRIMARY DOCUMENT 0001556244-17-000025 5442
2017-08-21 4 PRIMARY DOCUMENT 0001556244-17-000024 5529
2017-08-14 10-Q 170630 ASNB FORM 10-Q 0001011060-17-000022 001-11737 171029102 34 1277287 1
2017-07-25 10-K/A 170331 ASNB FORM 10-K/A#1 0001011060-17-000020 001-11737 17979542 34 194465
2017-06-26 10-K 170331 ASNB FORM 10-K 0001011060-17-000008 001-11737 17929142 34 2035630 1
2017-02-09 10-Q 161231 ASNB FORM 10-Q 0001011060-17-000005 001-11737 17587444 34 1293757 1
2016-11-16 10-Q/A 160930 ASNB FORM 10-Q/A #1 0001011060-16-000047 001-11737 162001953 34 911262 1
2016-11-14 10-Q 161114 ASNB FORM 10-Q 0001556244-16-000002 001-11737 161993434 34 279520
2016-08-12 10-Q 160630 ASNB FORM 10Q 0001011060-16-000044 001-11737 161828155 34 1172304 1
2016-07-29 10-K/A 160729 ASNB FORM 10-KA 0001011060-16-000041 001-11737 161792041 34 181076
2016-06-27 10-K 160331 ASNB FORM 10-K 0001011060-16-000038 001-11737 161733429 34 2077424 1
2016-04-20 3 PRIMARY DOCUMENT 0001672352-16-000001 8699
2016-02-12 10-Q 151231 ASNB FORM 10-Q 0001011060-16-000032 001-11737 161416524 34 1357961 1
2016-02-03 8-K 160203 ASNB FORM 8K 4.01,9.01 0001011060-16-000030 001-11737 161385846 34 19562
2015-12-01 4 PRIMARY DOCUMENT 0001011060-15-000026 4650
2015-11-16 10-Q 150930 IMSC FORM 10-Q 0001011060-15-000025 001-11737 151235934 34 1353857 1
2015-08-24 4 PRIMARY DOCUMENT 0001011060-15-000020 4651
2015-08-21 4 PRIMARY DOCUMENT 0001011060-15-000019 6161
2015-08-21 4 PRIMARY DOCUMENT 0001011060-15-000018 4651
2015-08-21 4 PRIMARY DOCUMENT 0001011060-15-000017 4650
2015-08-21 4/A PRIMARY DOCUMENT 0001011060-15-000016 5015
2015-08-20 4 PRIMARY DOCUMENT 0001011060-15-000015 6153
2015-08-14 10-Q 150630 ASNB FORM 10-Q 0001011060-15-000014 001-11737 151055203 34 1239169 1
2015-07-28 10-K/A 150728 ASNB FORM 10-KA#1 0001011060-15-000010 001-11737 151010541 34 195242
2015-07-14 10-K 150331 ASNB FORM 10-K 0001011060-15-000009 001-11737 15986374 34 2124973 1
2015-06-29 NT 10-K 150629 FORM 12B-25_150331 FORM 10K 0001011060-15-000004 001-11737 15959299 34 20798
2015-02-17 10-Q 141231 ASNB FORM 10-Q 0001011060-15-000002 001-11737 15620233 34 1670751 1
2014-12-11 8-K 141211 FORM 8K 5.02,7.01,9.01 0001011060-14-000035 001-11737 141281017 34 18149
2014-11-14 10-Q 140930 ASNB FORM 10-Q 0001011060-14-000033 001-11737 141222119 34 1583715 1
2014-08-13 10-Q 140630 ASNB FORM 10-Q 0001011060-14-000027 001-11737 141036504 34 1502723 1
2014-07-29 10-K/A 140331 FORM 10-KA AMENDMENT NO 1 0001011060-14-000024 001-11737 14999412 34 2201699 1
2014-07-14 10-K 140331 ASNB FORM 10-K 0001011060-14-000021 001-11737 14973525 34 461047
2014-06-30 NT 10-K 140630 ASNB FORM 12B-25 FOR 140331 FORM 10K 0001011060-14-000004 001-11737 14948488 34 19183
2014-02-14 10-Q 131231 FORM 10-Q 0001011060-14-000002 001-11737 14614330 34 1721242 1
2013-12-16 4 PRIMARY DOCUMENT 0001011060-13-000047 4650
2013-12-13 4 PRIMARY DOCUMENT 0001011060-13-000046 4651
2013-12-10 4 PRIMARY DOCUMENT 0001011060-13-000045 4651
2013-12-06 4 PRIMARY DOCUMENT 0001011060-13-000044 7630
2013-12-06 4 PRIMARY DOCUMENT 0001011060-13-000043 7671
2013-11-14 10-Q 130930 ASNB FORM 10-Q 0001011060-13-000042 001-11737 131218360 34 1722566 1
2013-09-09 4 PRIMARY DOCUMENT 0001011060-13-000038 4651
2013-09-06 3 PRIMARY DOCUMENT 0001011060-13-000037 4271
2013-09-06 4 PRIMARY DOCUMENT 0001011060-13-000036 5603
2013-09-06 4 PRIMARY DOCUMENT 0001011060-13-000035 5572
2013-09-06 4 PRIMARY DOCUMENT 0001011060-13-000034 5619
2013-09-06 4 PRIMARY DOCUMENT 0001011060-13-000033 5663
2013-09-03 4 PRIMARY DOCUMENT 0001011060-13-000032 4606
2013-08-28 8-K 130828 ASNB FORM 8-K 1.01,2.03,7.01,9.01 0001011060-13-000029 001-11737 131063851 34 132566
2013-08-27 4 PRIMARY DOCUMENT 0001011060-13-000031 5871
2013-08-27 4 PRIMARY DOCUMENT 0001011060-13-000030 5912
2013-08-13 10-Q 130630 ASNB FORM 10-Q 0001011060-13-000027 001-11737 131032940 34 2201360 1
2013-07-29 10-K/A 130331 ASNB FORM 10-K/A (AMENDMENT NO. 2) 0001011060-13-000023 001-11737 13991997 34 179377
2013-07-17 10-K/A 130331 FORM 10-K/A AMENDMENT NO. 1 FILED 130716 0001011060-13-000021 001-11737 13972318 34 3932753 1
2013-07-15 10-K U 0001011060-13-000010 001-11737 13968867 34 494591
2013-07-01 NT 10-K 130701 ASNB FORM 12B-25 FOR 130331 FORM 10-K 0001011060-13-000006 001-11737 13944805 34 28803
2013-02-13 10-Q 121231 ASNB FORM 10-Q 0001011060-13-000004 001-11737 13599927 34 1724825 1
2013-01-15 8-K 130115 ASNB FORM 8K 4.01,9.01 0001011060-13-000002 001-11737 13529936 34 19540
2012-12-17 4 PRIMARY DOCUMENT 0001011060-12-000053 7706
2012-12-12 4 PRIMARY DOCUMENT 0001011060-12-000052 4680
2012-12-10 4 PRIMARY DOCUMENT 0001011060-12-000051 4608
2012-12-10 4 PRIMARY DOCUMENT 0001011060-12-000050 4683
2012-12-06 4 PRIMARY DOCUMENT 0001011060-12-000049 6194
2012-12-05 4 PRIMARY DOCUMENT 0001011060-12-000048 4681
2012-12-04 4 PRIMARY DOCUMENT 0001011060-12-000047 4605
2012-12-03 4 PRIMARY DOCUMENT 0001011060-12-000046 4606
2012-11-28 4 PRIMARY DOCUMENT 0001011060-12-000045 6191
2012-11-21 4 PRIMARY DOCUMENT 0001011060-12-000044 6118
2012-11-21 4 PRIMARY DOCUMENT 0001011060-12-000043 7695
2012-11-14 10-Q ASNB 120930 FORM 10-Q 0001011060-12-000042 001-11737 121200968 34 1580722 1
2012-11-14 10-Q/A ASNB 120630 FORM 10-Q AMENDMENT #1 0001011060-12-000039 001-11737 121200857 34 624840 1
2012-11-13 10-K/A ASNB 120331 FORM 10-K/A AMENDMENT NO. 2 0001011060-12-000037 001-11737 121196706 34 1940963 1
2012-11-06 10-Q/A ASNB_DECEMBER 31, 2011_FORM 10-Q/A_AMENDMENT #1 0001011060-12-000033 001-11737 121181491 34 1255528 1
2012-10-19 10-Q/A 110930 FORM 10-Q/A AMENDMENT #1 FOR XBRL FILING 0001011060-12-000031 001-11737 121151252 34 1046216 1
2012-10-12 10-Q/A 110630_FORM 10-Q/A_AMENDMENT FOR XBRL FILING 0001011060-12-000028 001-11737 121141541 34 940310 1
2012-09-19 4 PRIMARY DOCUMENT 0001558093-12-000003 7631
2012-09-19 4 PRIMARY DOCUMENT 0001558093-12-000002 6197
2012-09-19 3 PRIMARY DOCUMENT 0001558093-12-000001 6282
2012-08-14 10-Q ASNB JUNE 30, 2012 FORM 10-Q 0001011060-12-000026 001-11737 121030967 34 235966
2012-07-27 10-K/A ADVANSOURCE 3/31/2012 FORM 10-K/A AMENDMENT NO. 1 0001011060-12-000022 001-11737 12991108 34 186043
2012-07-11 10-K ADVANSOURCE BIOMATERIALS FORM 10-K FOR 3/31/2012 0001011060-12-000018 001-11737 12957674 34 551011
2012-06-29 NT 10-K FORM 12B-25 FOR MARCH 31, 2012 FORM 10-K 0001011060-12-000013 001-11737 12936057 34 29109
2012-06-26 8-K UNITED STATES 5.02 0001011060-12-000009 001-11737 12927983 34 10647
2012-04-04 8-K 120404_ASNB_FORM 8K_MFA APPOINTMENT 4.01,9.01 0001011060-12-000006 001-11737 12741894 34 33241
2012-03-22 4 FORM 4 0001140361-12-017101 5076
2012-02-14 10-Q 111231_ASNB_FORM 10-Q 0001011060-12-000004 001-11737 12612989 34 496158
2012-02-14 SC 13G/A cg088.htm 0000897069-12-000178 005-48655 12603346 34 106979
2012-01-06 8-K 120106_ASNB FORM 8K_APPOINTMENT OF VOLPE AS CFO 5.02,7.01 0001011060-12-000002 001-11737 12514238 34 22646
2011-12-29 8-K 111229_ASNB FORM 8-K_SALE OF 229 ANDOVER STREET 1.01,1.02,2.01,9.01 0001011060-11-000023 001-11737 111287269 34 281353
2011-11-22 10-Q 110930 ASNB FORM 10-Q 0001011060-11-000021 001-11737 111222673 34 451712
2011-11-15 NT 10-Q 111115 FORM 12B-25 FOR 110930 FORM 10-Q 0001011060-11-000019 001-11737 111207322 34 29396
2011-10-12 4 FORM 4 0001140361-11-049142 5075
2011-10-07 8-K 111007 ASNB FORM 8-K_2011 ANNUAL MEETING VOTE RESULTS 5.07 0001011060-11-000017 001-11737 111133034 34 29682
2011-08-15 10-Q 110630 ASNB FORM 10-Q 0001011060-11-000015 001-11737 111036818 34 372380
2011-07-29 DEF 14A 110729_DEF14A_111004 ANNUAL MEETING 0001011060-11-000013 001-11737 11997586 34 355058
2011-07-14 10-K 110331 ASNB FORM 10-K 0001011060-11-000011 001-11737 11968595 34 995130
2011-07-13 8-K 110713 ASNB FORM 8-K_AXIOM CAPITAL PROMISSORY NOTE FINANCING 1.01,2.03,9.01 0001011060-11-000009 001-11737 11966029 34 281423
2011-06-30 NT 10-K 110630_ASNB_FORM 12B-25 0001011060-11-000007 001-11737 11940607 34 29585
2011-03-16 4 FORM 4 0001140361-11-017140 5075
2011-02-18 8-K 110218_FORM 8-K_110215 Q3-FY211 EARNINGS RELEASE 2.02,7.01,9.01 0001011060-11-000005 001-11737 11623484 34 218565
2011-02-14 10-Q 101231_ASNB_FORM 10Q 0001011060-11-000003 001-11737 11610766 34 470221
2011-02-08 SC 13G/A advansource2.htm 0000897069-11-000162 005-48655 11581790 34 83972
2010-12-06 25-NSE xslF25X02/primary_doc.xml 0001143313-10-000185 001-11737 34 18762
2010-11-15 10-Q 100930_ASB_FORM 10Q 0001011060-10-000012 001-11737 101193729 34 511480
2010-10-20 UPLOAD filename1.pdf 0000000000-10-061673 41410
2010-10-12 CORRESP filename1.htm 0001011060-10-000010 17404
2010-10-07 UPLOAD filename1.pdf 0000000000-10-059329 140378
2010-10-07 8-K 101006_ASB_FORM 8K_CHANGE IN AUDITOR 4.01,9.01 0001011060-10-000008 001-11737 101113482 34 37797
2010-10-07 8-K 101007_ASB_FORM 8K_APPOINTMENT OF MARK TAUSCHER AS DIRECTOR 5.02,7.01,9.01 0001011060-10-000005 001-11737 101113338 34 39911
2010-09-20 8-K 100917_ASB_FORM 8K_VOTE RESULTS OF 2010 ANNUAL MEETING 5.07 0001011060-10-000002 001-11737 101079946 34 35014
2010-09-09 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-10-017887 001-11737 10012528 34 1838
2010-09-08 4 FORM 4 0001140361-10-036484 5614
2010-08-23 8-K 100823_ASB_FORM 8K_AMEX DEFICIENCY LETTER 3.01,7.01,9.01 0001068874-10-000055 001-11737 101033213 34 43207
2010-08-20 8-K 100820_ASB_FORM 8K_Q1-FY2011 EARNINGS RELEASE PR 2.02,7.01,9.01 0001068874-10-000053 001-11737 101030539 34 136550
2010-08-13 10-Q 100630_ASB_FORM 10Q 0001068874-10-000051 001-11737 101015567 34 390138
2010-07-28 DEF 14A 100804_ASB_FORM DEF14A_2010 ANNUAL MEETING 0001068874-10-000047 001-11737 10973748 34 335412
2010-07-07 4 FORM 4 0001140361-10-028653 5990
2010-07-01 10-K 100331_ASB_FORM 10K 0001068874-10-000041 001-11737 10931744 34 993289
2010-06-30 NT 10-K 100630_ASB_FORM 12B-25 F0R 100331 FORM 10K 0001068874-10-000039 001-11737 10926113 34 29456
2010-05-03 4 FORM 4 0001140361-10-018487 7992
2010-02-18 8-K 100218_ASB_FORM 8K_Q3-FY2010 EARNINGS PR 2.02,7.01,9.01 0001068874-10-000013 001-11737 10616768 34 198221
2010-02-16 10-Q 091231_ASB_FORM 10Q 0001068874-10-000009 001-11737 10607622 34 582571
2010-01-21 SC 13G/A AMENDMENT NO. 1 0000897069-10-000049 005-48655 10538348 34 61420
2009-12-15 CT ORDER filename1.pdf 20091215,20091215 9999999997-09-027318 001-11737 091241246 34 20014
2009-12-11 10-K/A 090331_ASB_FORM 10K-A_AMENDMENT NO 1_FILED 091211 0001068874-09-000036 001-11737 091235501 34 147772
2009-11-12 10-Q 090930_ASB_FORM 10Q 0001011060-09-000043 001-11737 091174791 34 577735
2009-08-31 DEF 14A 091014_ASB_FORM DEF14A_2009 PROXY STATEMENT 0001011060-09-000040 001-11737 091045188 34 494597
2009-08-13 10-Q 090630_ASB_FORM 10Q 0001011060-09-000036 001-11737 091009817 34 591286
2009-08-13 8-K 090813_ASB_FORM 8K_Q1-2010 EARNINGS PR 2.02,7.01,9.01 0001011060-09-000034 001-11737 091008524 34 175953
2009-08-12 8-K 090812_ASB_FORM 8K_MEDOS SETTLEMENT 7.01,8.01,9.01 0001011060-09-000032 001-11737 091005369 34 119990
2009-07-01 10-K 090331_ASB_FORM 10K 0001011060-09-000024 001-11737 09920152 34 1463648
2009-06-30 NT 10-K 090630_ASB_FORM 12B-25_090331 FORM 10K 0001011060-09-000022 001-11737 09919490 34 27507
2009-06-03 4 FORM 4 0001140361-09-013857 5844
2009-05-12 4 FORM 4 0001140361-09-011982 5865
2009-05-12 4 FORM 4 0001140361-09-011979 5825
2009-05-12 4 FORM 4 0001140361-09-011967 5906
2009-05-12 4 FORM 4 0001140361-09-011960 5551
2009-04-01 8-K 090401_ASB_FORM 8K_CHANGE IN AUDITOR 4.01,9.01 0001011060-09-000012 001-11737 09722595 34 45259
2009-03-04 8-K 090302_ASB_CFO TERMINATION 1.01,5.02,7.01,9.01 0001011060-09-000002 001-11737 09656361 34 85513
2009-02-18 8-K 090218_ASB_FORM 8K_Q3-FY2009 EARNINGS RELEASE PR 2.02,7.01,9.01 0001068874-09-000018 001-11737 09617286 34 187197
2009-02-17 10-Q 081231_ASB_FORM 10Q 0001068874-09-000016 001-11737 09615837 34 593934
2009-01-27 SC 13G SCHEDULE 13G 0000897069-09-000112 005-48655 09548669 34 54398
2008-11-13 10-Q 080930_ASB_FORM 10Q 0001011060-08-000039 001-11737 081183319 34 591605
2008-11-12 8-K 081112_ASB_FORM 8K_Q2-2009 EARNINGS RELEASE PR 2.02,7.01,9.01 0001011060-08-000036 001-11737 081178601 34 183522
2008-10-30 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-08-044738 001-11737 08061444 34 1838
2008-09-08 4 FORM 4 0001140361-08-020894 5417
2008-09-08 4 FORM 4 0001140361-08-020892 5385
2008-08-27 DEF 14A 081015_CTE_DEF 14A 0001011060-08-000033 001-11737 081041934 34 438239
2008-08-14 PRE 14A 081015_CTE_PRE 14A 0001011060-08-000031 001-11737 081019801 34 438169
2008-08-13 10-Q 080630_CTE_FORM 10Q 0001011060-08-000029 001-11737 081014242 34 475708
2008-08-13 8-K 080813_CTE_FORM 8K_Q1FY09 EARNINGS PR 2.02,7.01,9.01 0001011060-08-000026 001-11737 081012236 34 150906
2008-08-08 4 FORM 4 0001140361-08-018642 5598
2008-07-18 4 FORM 4 0001140361-08-017274 7751
2008-06-27 10-K 080331_CTE_FORM 10K 0001011060-08-000024 001-11737 08923157 34 1926357
2008-06-25 8-K 080625_CTE_FORM 8K_FY2008 EARNINGS RELEASE 2.02,7.01,9.01 0001011060-08-000022 001-11737 08915886 34 203100
2008-06-19 4 FORM 4 0001140361-08-015323 7669
2008-06-19 4 FORM 4 0001140361-08-015322 5976
2008-06-18 4 FORM 4 0001140361-08-015232 5987
2008-06-18 4 FORM 4 0001140361-08-015230 5814
2008-06-18 4 FORM 4 0001140361-08-015223 5830
2008-06-18 4 FORM 4 0001140361-08-015199 5212
2008-06-17 4 FORM 4 0001140361-08-015141 5212
2008-05-30 4 FORM 4 0001140361-08-013944 5821
2008-04-03 8-K 080402_CTE_FORM 8K_CDT SALE 1.01,2.01,9.01 0001011060-08-000020 001-11737 08737672 34 284743
2008-02-22 S-8 080222_CTE_FORM S-8_WALTERS NONQUALIFIED STOCK OPTION 0001011060-08-000018 333-149343 08635561 33 271286
2008-02-22 S-8 080222_FORM S-8_REED NONQUALIFIED STOCK OPTION 0001011060-08-000016 333-149342 08635510 33 273725
2008-02-22 S-8 080222_FORM S-8_ESPP 0001011060-08-000014 333-149341 08635450 33 141638
2008-02-14 10-Q 071231_CTE_FORM 10Q 0001011060-08-000011 001-11737 08613583 34 829625
2008-02-12 8-K 080212_FORM 8K_Q3FY2008 EARNINGS RELEASE 2.02,7.01,9.01 0001011060-08-000009 001-11737 08595877 34 215331
2008-02-06 4 FORM 4 0001140361-08-002915 5895
2008-01-31 8-A12G 080130 FORM 8-A RIGHTS AGREEMENT 0001011060-08-000007 000-28034 08562663 34 51276
2008-01-29 8-K 080129 FORM 8K STOCKHOLDERS RIGHTS AGREEMENT 1.01,3.03,5.03,9.01 0001011060-08-000004 001-11737 08558808 34 441272
2008-01-29 4 FORM 4 0001140361-08-002147 5891
2007-12-21 8-K 071221_CTE_FORM 8K_AMENDMENT TO SEC 3.01 OF BY0LAWS 5.03 0001011060-07-000005 001-11737 071323126 34 42132
2007-11-14 10-Q FORM 10-Q 0001047469-07-009233 001-11737 071243851 34 305010
2007-11-13 8-K 8-K 2.02,7.01,9.01 0001104659-07-082317 001-11737 071236479 34 224742
2007-11-07 4 FORM 4 0001140361-07-021279 7597
2007-11-07 4 FORM 4 0001140361-07-021271 5630
2007-11-06 4 FORM 4 0001140361-07-021152 7102
2007-11-02 4 FORM 4 0001140361-07-020860 5019
2007-11-01 4 FORM 4 0001140361-07-020745 5019
2007-11-01 4 FORM 4 0001140361-07-020723 7335
2007-10-29 4 FORM 4 0001140361-07-020521 5019
2007-10-26 4 FORM 4 0001140361-07-020473 5019
2007-10-26 4 FORM 4 0001140361-07-020472 7332
2007-10-25 4 FORM 4 0001140361-07-020390 6654
2007-10-23 4 FORM 4 0001140361-07-020301 5019
2007-10-23 4 FORM 4 0001140361-07-020300 7335
2007-10-23 4 FORM 4 0001140361-07-020298 7332

Latest XBRL company facts

One latest value per concept from companyfacts (393 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 19.44M 2026-09-21 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
dei EntityPublicFloat Entity Public Float USD 21.13M 2025-09-30 2026 FY 10-K 2026-07-14 0001493152-26-033203
srt StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased shares 0 2025-09-30 2026 Q2 10-Q 2025-11-14 0001493152-25-023246
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 185,000 2019-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap AccountsPayable Accounts Payable (Deprecated 2009-01-31) USD 142,000 2013-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.58M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 12,500 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 497,000 2019-12-31 2020 Q3 10-Q 2020-04-01 0001493152-20-005627
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 535,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 60,000 2013-03-31 2014 FY 10-K 2014-07-29 0001011060-14-000024
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 12,127 2023-03-31 2023 FY 10-K/A 2023-07-20 0001493152-23-024963
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 436,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 63,000 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap AccruedFeesAndOtherRevenueReceivable Accrued Fees and Other Revenue Receivable USD 241,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap AccruedLiabilities Accrued Liabilities (Deprecated 2009-01-31) USD 227,000 2013-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 237,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 446,000 2019-12-31 2020 Q3 10-Q 2020-04-01 0001493152-20-005627
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2,946 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets USD -2,988 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 3.77M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 111.15M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 38.61M 2019-12-31 2020 Q3 10-Q 2020-04-01 0001493152-20-005627
us-gaap AdjustmentForAmortization Amortization USD 1,298 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 775 2023-10-01 2023-12-31 2025 Q3 10-Q 2025-04-02 0001641172-25-002308
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 167,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 550,000 2022-10-01 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004887
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 19,000 2018-07-01 2018-09-30 2020 Q3 10-Q 2020-04-01 0001493152-20-005627
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 775 2023-04-01 2024-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD 193,330 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 23,000 2018-04-01 2019-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap AdvertisingExpense Advertising Expense USD 1.00M 2019-04-01 2020-01-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2025-04-01 2025-06-30 2026 Q1 10-Q 2025-08-20 0001641172-25-024884
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 5.00M 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2020-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 5,000 2011-04-01 2011-09-30 2012 Q2 10-Q 2012-11-14 0001011060-12-000042
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 7.00M 2017-04-01 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.00M 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap AntidilutiveSharesOutstanding Antidilutive Shares Outstanding (Deprecated 2009-01-31) shares 2.06M 2012-04-01 2012-12-31 2012 Q3 10-Q 2013-02-13 0001011060-13-000004
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-04-01 2025-06-30 2026 Q1 10-Q 2025-08-20 0001641172-25-024884
us-gaap Assets Assets USD 73.10M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap AssetsCurrent Assets, Current USD 298,402 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 2.09M 2019-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 2.02M 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap BuildingsAndImprovementsGross Buildings and Improvements, Gross USD 2,705 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 1.63M 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 15.84M 2024-05-13 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 134,572 2024-05-13 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 3.48M 2024-05-13 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 12.36M 2024-05-13 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 19.00M 2024-05-13 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap CapitalLeasedAssetsGross Capital Leased Assets, Gross USD 13 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 1,000 2016-03-31 2017 FY 10-K 2017-06-26 0001011060-17-000008
us-gaap Cash Cash USD 5,784 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 150,186 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 38,788 2023-12-31 2024 Q3 10-Q 2024-02-06 0001493152-24-005068
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 284,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5,784 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 10,772 2023-09-30 2024 Q2 10-Q 2023-11-13 0001493152-23-040448
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -15,270 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -239,461 2022-04-01 2023-03-31 2023 FY 10-K 2023-07-14 0001493152-23-024627
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 150,000 2020-09-30 2021 Q2 10-Q 2021-09-10 0001493152-21-022389
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -27,000 2018-04-01 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 107,000 2019-04-01 2019-12-31 2021 Q3 10-Q 2021-09-13 0001493152-21-022555
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 1 2022-04-11 2022 Q1 10-Q 2022-08-26 0001493152-22-024151
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.00M 2024-12-30 2026 Q1 10-Q 2025-08-20 0001641172-25-024884
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 6.00M 2022-04-11 2022 Q1 10-Q 2022-08-26 0001493152-22-024151
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 50.00M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 19.23M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 19.17M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap CommonStockValue Common Stock, Value, Issued USD 19,232 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -2.85M 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ConcentrationRiskPercentage Concentration Risk, Percentage (Deprecated 2012-01-31) pure 0.71 2013-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 0.53 2018-04-01 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 7,500 2024-03-31 2024 FY 10-K 2024-07-03 0001493152-24-026126
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 7,500 2024-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 447,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 173,000 2018-04-01 2018-06-30 2019 Q1 10-Q 2018-08-14 0001556244-18-000107
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 15,000 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap CustomerAdvancesCurrent Customer Advances, Current USD 25 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 13 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD -169,000 2011-04-01 2011-12-31 2012 Q3 10-Q 2013-02-13 0001011060-13-000004
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 5,000 2020-01-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 54,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 59,000 2011-09-30 2011 Q2 10-Q/A 2012-10-19 0001011060-12-000031
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 9,406 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 9.32M 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 9.92M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap DeferredRevenue Deferred Revenue USD 25,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2019-03-31 2019 FY 10-K 2019-08-23 0001376474-19-000225
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 125 2015-03-31 2016 FY 10-K 2016-06-27 0001011060-16-000038
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 5.33M 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 23,000 2019-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 9,502 2015-03-31 2015 FY 10-K 2015-07-14 0001011060-15-000009
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3.18M 2022-03-31 2022 FY 10-K 2022-06-28 0001493152-22-017952
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 5.30M 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 9,187 2015-03-31 2015 FY 10-K 2015-07-14 0001011060-15-000009
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 35,000 2019-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 124,000 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 292 2015-03-31 2015 FY 10-K 2015-07-14 0001011060-15-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 46 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 45 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 53 2015-03-31 2015 FY 10-K 2015-07-14 0001011060-15-000009
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 5.33M 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 9.32M 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 9.32M 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 153,000 2019-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD -172 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 0 2012-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 47 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap Depreciation Depreciation USD 28,000 2019-04-01 2019-09-30 2021 Q2 10-Q 2021-09-10 0001493152-21-022389
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD 5,000 2018-04-01 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap DepreciationExpense Depreciation Expense (Deprecated 2009-01-31) USD 137,000 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap DerivativeLiabilities Derivative Liability USD 280,000 2024-12-31 2025 Q3 10-Q 2025-04-02 0001641172-25-002308
us-gaap DilutiveSecuritiesEffectOnBasicEarningsPerShareOther Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities USD 3.00M 2016-04-01 2016-12-31 2017 Q3 10-Q 2017-02-09 0001011060-17-000005
us-gaap DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax Discontinued Operation, Amount of Adjustment to Prior Period Gain (Loss) on Disposal, Net of Tax USD 5.71M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax USD 5.70M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax USD 5.70M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share USD/shares 0 2020-04-01 2021-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share USD/shares 0 2020-04-01 2021-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold Disposal Group, Including Discontinued Operation, Costs of Goods Sold USD 719,000 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense Disposal Group, Including Discontinued Operation, General and Administrative Expense USD 1.28M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss Disposal Group, Including Discontinued Operation, Gross Profit (Loss) USD 1.98M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationInterestExpense Disposal Group, Including Discontinued Operation, Interest Expense USD 398,000 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationInventory1 Disposal Group, Including Discontinued Operation, Inventory USD 271,000 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 1.59M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherExpense Disposal Group, Including Discontinued Operation, Other Expense USD 398,000 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment USD 1.75M 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 2.70M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap Dividends Dividends USD 5.09M 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-28 0001493152-22-017952
us-gaap DividendsPayableAmountPerShare Dividends Payable, Amount Per Share USD/shares 0.18 2022-03-31 2022 FY 10-K 2022-06-28 0001493152-22-017952
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 10,000 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004887
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.13 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.02 2015-04-01 2015-09-30 2016 Q2 10-Q 2015-11-16 0001011060-15-000025
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.13 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2022-04-01 2023-03-31 2023 FY 10-K/A 2023-07-20 0001493152-23-024963
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.25 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-04-01 2019-03-31 2019 FY 10-K 2019-08-23 0001376474-19-000225
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Percent pure 0.189 2017-04-01 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.004 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2022-04-01 2023-03-31 2023 FY 10-K/A 2023-07-20 0001493152-23-024963
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.677 2017-04-01 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2022-04-01 2023-03-31 2023 FY 10-K/A 2023-07-20 0001493152-23-024963
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.115 2012-04-01 2013-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.063 2022-04-01 2023-03-31 2023 FY 10-K/A 2023-07-20 0001493152-23-024963
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0 2012-04-01 2013-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.093 2017-04-01 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 176 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -3,165 2023-04-01 2023-09-30 2024 Q2 10-Q 2023-11-13 0001493152-23-040448
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 5.01M 2022-04-01 2022-09-30 2023 Q2 10-Q 2022-11-14 0001493152-22-031822
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 138,979 2024-04-01 2024-06-30 2026 Q1 10-Q 2025-08-20 0001641172-25-024884
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 0 2025-06-30 2026 Q1 10-Q 2025-08-20 0001641172-25-024884
us-gaap EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwards Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards (Deprecated 2011-01-31) USD 32,000 2013-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwardsWeightedAveragePeriodOfRecognition Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards, Weighted Average Period of Recognition (Deprecated 2011-01-31) pure 2.67 2013-12-30 2013-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 671,250 2024-04-01 2025-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 172,715 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 0.874 2013-06-30 2013 Q1 10-Q 2013-08-13 0001011060-13-000027
us-gaap FairValueConcentrationOfRiskAccountsReceivable Fair Value, Concentration of Risk, Accounts Receivable USD 290,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD -234,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 0 2019-12-31 2020 Q3 10-Q 2020-04-01 0001493152-20-005627
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -163 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -1.49M 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -36,000 2013-04-01 2014-03-31 2015 FY 10-K 2015-07-14 0001011060-15-000009
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 151,000 2011-04-01 2012-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 43,798 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap Goodwill Goodwill USD 26.91M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 25.25M 2024-04-01 2025-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -247,303 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap GrossProfit Gross Profit USD 1.18M 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2012-04-01 2013-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -226,000 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-09-13 0001493152-21-022555
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -1.28M 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -2.31M 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -2.77M 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -47,000 2021-04-01 2021-06-30 2022 Q1 10-Q 2021-09-23 0001493152-21-023473
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.01 2020-04-01 2021-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.01 2020-04-01 2021-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 5.70M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 388,000 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0.24 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0.24 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD 0 2022-04-01 2022-09-30 2023 Q2 10-Q 2022-11-14 0001493152-22-031822
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 15,000 2020-04-01 2021-03-31 2022 FY 10-K 2022-06-28 0001493152-22-017952
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 223,626 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 3,830 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -188,090 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -185,000 2019-04-01 2020-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 30,000 2019-04-01 2019-12-31 2020 Q3 10-Q 2020-04-01 0001493152-20-005627
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 752,982 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -12,127 2023-04-01 2024-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -63,000 2020-04-01 2021-03-31 2022 FY 10-K 2022-06-28 0001493152-22-017952
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 104,000 2019-04-01 2019-12-31 2020 Q3 10-Q 2020-04-01 0001493152-20-005627
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -2,500 2025-04-01 2025-09-30 2026 Q2 10-Q 2025-11-14 0001493152-25-023246
us-gaap IncreaseDecreaseInCustomerAdvances Increase (Decrease) in Customer Advances USD 1,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap IncreaseDecreaseInDeferredChargesInvesting Increase (Decrease) in Deferred Charges, Investing USD -170,000 2011-04-01 2012-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -2,500 2025-04-01 2025-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD -37,000 2013-04-01 2014-03-31 2015 FY 10-K 2015-07-14 0001011060-15-000009
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -6,000 2022-04-01 2022-09-30 2023 Q2 10-Q 2022-11-14 0001493152-22-031822
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 4,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD 81 2018-04-01 2019-03-31 2019 FY 10-K 2019-08-23 0001376474-19-000225
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -11,053 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 116,727 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 19 2023-04-01 2023-06-30 2023 Q1 10-Q 2023-08-18 0001493152-23-029390
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -44,481 2023-04-01 2024-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 3,103 2025-09-30 2026 Q2 10-Q 2025-11-14 0001493152-25-023246
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 269,000 2015-04-01 2015-12-31 2016 Q3 10-Q 2016-02-12 0001011060-16-000032
us-gaap InterestExpense Interest Expense USD 382 2022-04-01 2023-03-31 2024 FY 10-K 2024-07-03 0001493152-24-026126
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1,942 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 175,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 393,000 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap InterestPortionOfMinimumLeasePaymentsSaleLeasebackTransactions Interest Portion of Minimum Lease Payments, Sale Leaseback Transactions USD 172,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 153 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap InventoryFinishedGoodsAndWorkInProcessNetOfReserves Inventory, Finished Goods and Work in Process, Net of Reserves USD 252 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 129 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap InventoryNet Inventory, Net USD 271,000 2020-01-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 135 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 182 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD -81 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 45 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 43 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap InventoryWriteDown Inventory Write-down USD 0 2018-04-01 2019-03-31 2019 FY 10-K 2019-08-23 0001376474-19-000225
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1,913 2023-04-01 2023-06-30 2023 Q1 10-Q 2023-08-18 0001493152-23-029390
us-gaap InvestmentIncomeNet Investment Income, Net USD 1,913 2023-04-01 2023-06-30 2025 Q1 10-Q 2024-08-19 0001493152-24-033179
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 16 2013-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 138,979 2024-04-01 2024-12-31 2026 Q3 10-Q 2026-02-13 0001493152-26-006646
us-gaap Land Land USD 500 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap Liabilities Liabilities USD 11.59M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 73.10M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.67M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 2,146 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 2.15M 2019-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 214,000 2018-04-01 2018-06-30 2019 Q1 10-Q 2018-08-14 0001556244-18-000107
us-gaap LongLivedAssetsHeldForSaleProceedsFromSale Long Lived Assets Held-for-sale, Proceeds from Sale (Deprecated 2013-01-31) USD 2.00M 2011-12-22 2015 Q3 10-Q 2015-02-17 0001011060-15-000002
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 1.99M 2020-01-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months USD -7,000 2016-03-31 2016 FY 10-K 2016-06-27 0001011060-16-000038
us-gaap LongTermInvestments Long-term Investments USD 763,000 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap LongTermNotesAndLoans Notes and Loans, Noncurrent USD 800,000 2011-09-30 2011 Q2 10-Q/A 2012-10-19 0001011060-12-000031
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 1,248 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD -75,342 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 145,750 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1,176 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -159,844 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -272,000 2020-04-01 2020-12-31 2021 Q3 10-Q 2021-09-13 0001493152-21-022555
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -2.28M 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -45,118 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest USD 12 2019-07-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap NoncontrollingInterestIncreaseFromBusinessCombination Noncontrolling Interest, Increase from Business Combination USD 450,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -1.49M 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap NotesPayable Notes Payable USD 140,000 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap NotesPayableCurrent Notes Payable, Current USD 82,000 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 140,000 2019-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 115,354 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 5,000 2021-04-01 2021-06-30 2022 Q1 10-Q 2021-09-23 0001493152-21-023473
us-gaap OperatingExpenses Operating Expenses USD 819,624 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -819,624 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 25.19M 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 160,000 2016-03-31 2016 FY 10-K 2016-06-27 0001011060-16-000038
us-gaap OtherAmortizationOfDeferredCharges Amortization of Other Deferred Charges USD 3,000 2019-04-01 2019-09-30 2021 Q2 10-Q 2021-09-10 0001493152-21-022389
us-gaap OtherAssets Other Assets USD 49,305 2024-12-31 2025 Q3 10-Q 2025-04-02 0001641172-25-002308
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 24,220 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 3.70M 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -540,292 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD 735,953 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest USD -302,172 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap OtherExpenses Other Expenses USD 371,000 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-27 0001011060-16-000038
us-gaap OtherIncome Other Income USD -45,000 2013-04-01 2014-03-31 2015 FY 10-K 2015-07-14 0001011060-15-000009
us-gaap OtherLiabilities Other Liabilities USD 167,000 2025-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 13,886 2023-03-31 2023 FY 10-K/A 2023-07-20 0001493152-23-024963
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 164 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 9,380 2023-04-01 2023-06-30 2025 Q1 10-Q 2024-08-19 0001493152-24-033179
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 9,386 2023-04-01 2024-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap PaymentsForProceedsFromLimitedPartnership Payments for (Proceeds from) Limited Partnership USD 140,000 2025-06-30 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 78,394 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap PaymentsForSoftware Payments for Software USD 2,374 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap PaymentsOfCapitalDistribution Payments of Capital Distribution USD 775 2023-04-01 2024-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 2,880 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap PaymentsToAcquireEquipmentOnLease Payments to Acquire Equipment on Lease USD 2.15M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 2,374 2024-04-01 2025-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 0 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 8,794 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2024-11-08 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2024-12-31 2025 Q3 10-Q 2025-04-02 0001641172-25-002308
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2024-06-30 2025 Q1 10-Q 2024-08-19 0001493152-24-033179
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-06-30 2025 Q1 10-Q 2024-08-19 0001493152-24-033179
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 292,618 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1,000 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004887
us-gaap PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions Present Value of Future Minimum Lease Payments, Sale Leaseback Transactions USD 1,986 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 193,330 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 123,750 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 22,000 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 2.00M 2011-04-01 2011-12-31 2011 Q3 10-Q/A 2012-11-06 0001011060-12-000033
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 13,886 2022-04-01 2023-03-31 2024 FY 10-K 2024-07-03 0001493152-24-026126
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 11,635 2023-04-01 2023-12-31 2025 Q3 10-Q 2025-04-02 0001641172-25-002308
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 45,000 2013-04-01 2014-03-31 2015 FY 10-K 2015-07-14 0001011060-15-000009
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 2.09M 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 7,618 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 889,477 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap ProfessionalFees Professional Fees USD 222,587 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.31M 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap PropertyPlantAndEquipmentAdditions Property, Plant and Equipment, Additions USD -10,000 2017-04-01 2017-12-31 2018 Q3 10-Q 2018-02-14 0001556244-18-000030
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4,724 2012-06-30 2012 Q2 10-Q 2012-11-14 0001011060-12-000042
us-gaap PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease Property, Plant and Equipment, Gross, Period Increase (Decrease) USD 13,000 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-27 0001011060-16-000038
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 8,369 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap PropertyPlantAndEquipmentOtherNet Property, Plant and Equipment, Other, Net USD 146,000 2012-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap PropertyPlantAndEquipmentOwnedGross Property, Plant, and Equipment, Owned, Gross USD 4,725 2013-06-30 2013 Q1 10-Q 2013-08-13 0001011060-13-000027
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 44,481 2023-03-31 2024 FY 10-K 2024-07-03 0001493152-24-026126
us-gaap RelatedPartyTransactionDueFromToRelatedPartyCurrent Related Party Transaction, Due from (to) Related Party, Current USD 125 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD -1,000 2016-04-01 2016-12-31 2018 Q3 10-Q 2018-02-14 0001556244-18-000030
us-gaap RepaymentsOfFirstMortgageBond Repayments of First Mortgage Bond USD -5,000 2018-04-01 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 40,000 2022-04-01 2023-03-31 2024 FY 10-K 2024-07-03 0001493152-24-026126
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 140,000 2019-04-01 2020-03-31 2021 FY 10-K 2021-09-22 0001493152-21-023342
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 437,885 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -53.25M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 5,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 2.70M 2019-04-01 2020-01-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap Revenues Revenues USD 1.63M 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 452,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 428,000 2018-04-01 2018-09-30 2019 Q2 10-Q 2018-11-14 0001556244-18-000162
us-gaap SaleLeasebackTransactionAmountDueUnderFinancingArrangement Sale Leaseback Transaction, Amount Due under Financing Arrangement USD 1.99M 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap SaleLeasebackTransactionGrossProceeds Sale Leaseback Transaction, Gross Proceeds (Deprecated 2014-01-31) USD 2.00M 2011-12-21 2011-12-22 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap SaleLeasebackTransactionHistoricalCost Sale Leaseback Transaction, Historical Cost USD 2.00M 2018-12-31 2019 Q3 10-Q 2019-02-19 0001556244-19-000027
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 39.00M 2024-11-12 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 3.25 2024-11-12 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 375,000 2018-04-01 2018-06-30 2019 Q1 10-Q 2018-08-14 0001556244-18-000107
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 956,000 2018-04-01 2018-09-30 2019 Q2 10-Q 2018-11-14 0001556244-18-000162
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 674,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-13 0001556244-19-000102
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 137,544 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 159,228 2024-04-01 2024-12-31 2025 Q3 10-Q 2025-04-02 0001641172-25-002308
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 1.9 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.79 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 7.00M 2024-06-07 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 51,000 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 550,000 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 972,500 2019-04-01 2020-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 0 2024-04-01 2024-09-30 2025 Q2 10-Q 2024-11-14 0001493152-24-045927
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 100,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.38 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 51,000 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 925,000 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 51,000 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 550,000 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 3 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 33,000 2012-04-01 2013-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.39 2024-04-01 2025-03-31 2025 FY 10-K 2025-07-29 0001641172-25-021335
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.06 2019-04-01 2020-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.29 2019-04-01 2020-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.9 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap SharePrice Share Price USD/shares 1.9 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap SharesUsedInComputationOfBasicEarningsLossPerShare Shares Used in Computation of Basic Earnings (Loss) Per Share (Deprecated 2009-01-31) shares 21,491 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap SharesUsedInComputationOfDilutedEarningsLossPerShare Shares Used in Computation of Diluted Earnings (Loss) Per Share (Deprecated 2009-01-31) shares 21,491 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001011060-14-000002
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 23 2018-04-01 2019-03-31 2019 FY 10-K 2019-08-23 0001376474-19-000225
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 61.59M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 61.51M 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap StockIssued1 Stock Issued USD 19.00M 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 0 2012-04-01 2013-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 30,000 2025-04-01 2025-06-30 2026 Q1 10-Q 2025-08-20 0001641172-25-024884
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 656,250 2019-04-01 2020-03-31 2020 FY 10-K 2021-07-16 0001493152-21-017036
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 39.00M 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 7,000 2011-04-01 2012-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 304,800 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 123,750 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 19.00M 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 1,568 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 137,544 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 895,193 2024-04-01 2025-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 0 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-01-14 0001493152-22-001233
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 78,394 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001493152-26-033203
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 57,796 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap TreasuryStockShares Treasury Stock, Shares shares 1,534 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004887
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 0 2021-04-01 2021-09-30 2022 Q2 10-Q 2021-11-12 0001493152-21-028097
us-gaap TreasuryStockValue Treasury Stock, Value USD 108,722 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-03-31 2024 FY 10-K 2024-07-03 0001493152-24-026126
us-gaap ValuationAllowancesAndReservesPeriodIncreaseDecrease SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) USD -30,000 2017-04-01 2018-03-31 2018 FY 10-K 2018-07-16 0001556244-18-000089
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 8.91 2024-12-30 2026 Q1 10-Q 2025-08-20 0001641172-25-024884
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 76,000 2008-03-31 2012 FY 10-K/A 2013-07-17 0001011060-13-000021
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 607,500 2024-04-01 2024-09-30 2025 Q2 10-Q 2024-11-14 0001493152-24-045927
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 19.17M 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 21.49M 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-27 0001011060-16-000038
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 19.17M 2026-04-01 2026-06-30 2027 Q1 10-Q 2026-09-28 0001493152-26-044551

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →